A

A randomized controlled trial comparing tibial migration of the ATTUNE cemented cruciate-retaining knee prosthesis with the PFC-sigma design

The Bone & Joint Journal, vol. 102-B, pp. 1158–1166

Abstract

Aims The primary objective of this study was to compare migration of the cemented ATTUNE fixed bearing cruciate retaining tibial component with the cemented Press-Fit Condylar (PFC)-sigma fixed bearing cruciate retaining tibial component. The secondary objectives included comparing clinical and radiological outcomes and Patient Reported Outcome Measures (PROMs). Methods A single blinded randomized, non-inferiority study was conducted including 74 patients. Radiostereometry examinations were made after weight bearing, but before hospital discharge, and at three, six, 12, and 24 months postoperatively. PROMS were collected preoperatively and at three, six, 12, and 24 months postoperatively. Radiographs for measuring radiolucencies were collected at two weeks and two years postoperatively. Results The overall migration (mean maximum total point motion (MPTM)) at two years was comparable: mean 1.13 mm (95% confidence interval (CI), 0.97 to 1.30) for the ATTUNE and 1.16 mm (95% CI, 0.99 to 1.35) for the PFC-sigma. At two years, the mean backward tilting was -0.43° (95% CI, -0.65 to -0.21) for the ATTUNE and 0.08° (95% CI -0.16 to 0.31), for the PFC-sigma. Overall migration between the first and second postoperative year was negligible for both components. The clinical outcomes and PROMs improved compared with preoperative scores and were not different between groups. Radiolucencies at the implant-cement interface were mainly seen below the medial baseplate: 17% in the ATTUNE and 3% in the PFC-sigma at two weeks, and at two years 42% and 9% respectively (p = 0.001). Conclusion In the first two postoperative years the initial version of the ATTUNE tibial component was not inferior with respect to overall migration, although it showed relatively more backwards tilting and radiolucent lines at the implant-cement interface than the PFC-sigma. The version of the ATTUNE tibial component examined in this study has subsequently undergone modification by the manufacturer. Level of Evidence: 1 (randomized controlled clinical trial) Cite this article: Bone Joint J 2020;102-B(9):1158–1166.

Authors 5

  1. Leiden University Medical Center

    Affiliation as printed

    Department of Orthopaedics, Leiden University Medical Center, Leiden, Netherlands

    From Leiden University Medical Center, Leiden, Netherlands

  2. Medisch Centrum Haaglanden · Stichting Haaglanden Medisch Centrum

    Affiliation as printed

    Department of Orthopaedic Surgery, Haaglanden Medical Center, The Hague, Netherlands

  3. The Hague University of Applied Sciences

    Affiliation as printed

    Faculty Health, Nutrition and Sports, The Hague University of Applied Sciences, The Hague, Netherlands

  4. Leiden University · Leiden University Medical Center

    Affiliation as printed

    Mathematical Institute, Leiden University, Leiden, The Netherlands

    Medical Statistics, Department of Biomedical Data Sciences, Leiden University Medical Center, Leiden, Netherlands

  5. Leiden University Medical Center

    Affiliation as printed

    Department of Orthopaedics, Leiden University Medical Center, Leiden, Netherlands

Cited by 30 stored of 30

No patents citing this paper on Lens.org (checked 2026-10-11).

References 40